Comments
Loading...
AbCellera Biologics (NASDAQ:ABCL) Stock, Earnings Estimates, EPS, And Revenue
AbCellera Biologics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Feb 27
EPS Estimate
$-0.150
Quarterly Revenue Estimate
$7.58M
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$32.96M
Analyze the earnings history of AbCellera Biologics using advanced sorting and filters.
Data brought to you by Benzinga APIs
AbCellera Biologics (ABCL) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-04 | $-0.17 | $-0.15 | -13.3 % |
| Q2 | 2024-08-06 | $-0.13 | $-0.14 | 7.14 % |
| Q1 | 2024-05-07 | $-0.14 | $-0.17 | 17.6 % |
| Q4 | 2024-02-20 | $-0.16 | $-0.13 | -23.1 % |
AbCellera Biologics (ABCL) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-04 | $6.51M | $7.95M | -18.1 % |
| Q2 | 2024-08-06 | $7.32M | $10.15M | -27.9 % |
| Q1 | 2024-05-07 | $9.95M | $10.84M | -8.17 % |
| Q4 | 2024-02-20 | $9.18M | $8.88M | 3.37 % |
FAQ
When is AbCellera Biologics (NASDAQ:ABCL) reporting earnings?
AbCellera Biologics (ABCL) is scheduled to report earnings on February 27, 2025. The last reported earnings were for reported on November 4, 2024 for Q3.
What were the latest earnings per share (EPS) for AbCellera Biologics (NASDAQ:ABCL)?
The Actual EPS was $-0.17, which missed the estimate of $-0.15.
What were AbCellera Biologics’s (NASDAQ:ABCL) revenues?
The Actual Revenue was $6.5M, which missed the estimate of $8M.
Browse earnings estimates, EPS, and revenue on all stocks.